NCT04189445 2025-10-08Futibatinib in Patients With Specific FGFR AberrationsTaiho Oncology, Inc.Phase 2 Terminated115 enrolled 19 charts
NCT02052778 2025-03-27A Study of TAS-120 in Patients With Advanced Solid TumorsTaiho Oncology, Inc.Phase 1/2 Completed407 enrolled 45 charts 2 FDA
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled